TYK2 in Cancer Metastases: Genomic and Proteomic Discovery

SIMPLE SUMMARY: Cancer deaths are predominantly due to metastases rather than the primary tumors, and thus there is an urgent need for the discovery of more effective drug therapies for metastatic cancer. Recent genomics, transcriptomics, and proteomics studies have identified tyrosine kinase 2 (TYK...

Descripción completa

Detalles Bibliográficos
Autores principales: Borcherding, Dana C., He, Kevin, Amin, Neha V., Hirbe, Angela C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393599/
https://www.ncbi.nlm.nih.gov/pubmed/34439323
http://dx.doi.org/10.3390/cancers13164171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393599/
https://www.ncbi.nlm.nih.gov/pubmed/34439323
http://dx.doi.org/10.3390/cancers13164171

Ejemplares similares